In 2015, a Cognitive Vitality Report released by the Alzheimers Drug Discovery Foundation stated that two multi-year treatment trials had found that epithalamin, from which epitalon is isolated, had imparted no severe adverse events in older adults, and that preclinical trials supported a favorable safety profile.35 Ten years later, a systematic review published in 2025 stated that information regarding critical issues about this peptides safety is missing.1 In terms of human trials, the best case we have in support of epitalons safety is a 2002 trial involving 162 patients in which no one in the epitalon group reported serious side effects.36 At the same time, the U.S
The electron transfer from NADH+ and FADH+ to NAD and FAD by complexes 1 and 4 produce O 2 radicals which are then converted into H 2 O 2 enzymatically by the catalytic activity of SOD
Glutathione does not produce acute subjective effects the benefit is cumulative over weeks as hepatic antioxidant capacity improves
References [i] Pollard, J
Its most-researched applications in preclinical models include gastric ulcer healing, inflammatory bowel disease, leaky gut, and intestinal repair
[DOI] [PubMed] [Google Scholar] 3.Sikiric P., Hahm K.B., Blagaic A.B., Tvrdeic A., Pavlov K.H., Petrovic A., Kokot A., Gojkovic S., Krezic I., Drmic D., et al
